BPC-157 — Research Summary
Overview
Body Protection Compound-157 (BPC-157) is a synthetic pentadecapeptide derived from a partial sequence of body protection compound discovered in human gastric juice. It has been the subject of extensive preclinical research examining tissue repair mechanisms. Originally identified as a fragment of a larger protective protein found in gastric juice, BPC-157 has been classified as a stable gastric pentadecapeptide due to its documented resistance to enzymatic degradation in physiological conditions. Since its initial characterization, this 15-amino acid peptide has been the subject of more than three decades of published research, with studies spanning in vitro cell culture experiments, various animal models, and systematic reviews. Researchers have examined its interactions with multiple signaling pathways implicated in tissue remodeling, including nitric oxide systems, growth factor receptors, and cytoskeletal regulation. The compound's stability in acidic environments and its origin from gastric secretions have made it a subject of particular interest in the study of gastrointestinal peptide biology. Its documented interactions with the FAK-paxillin pathway and growth hormone receptor expression have been explored across multiple tissue types in preclinical settings.
Compound Profile
The following specifications characterize the BPC-157 research compound as supplied for laboratory investigation purposes.
| Compound Name | BPC-157 |
| Designation | BPC-157 — 10 mg |
| Sequence / Structure | GEPPPGKPADDAGLV (15 amino acids, MW 1419) |
| Purity | ≥99% |
| Form | Lyophilized powder |
| Vial Size | 10mg |
| Storage | Refrigerated after reconstitution |
| Research Category | Tissue Research |
| Series | Recovery Series |
| SKU | BC-10 |
Published Research
The following findings have been documented in peer-reviewed publications and scientific literature. These summaries reflect reported observations and are presented for informational purposes in support of laboratory research activities.
- A 2025 systematic review in the Orthopaedic Journal of Sports Medicine (Vasireddi et al.) analyzed 36 studies from 1993–2024, reporting that BPC-157 enhanced growth hormone receptor expression and multiple pathways involved in cell growth and angiogenesis in preclinical models.
- Research published in the Journal of Applied Physiology (Chang et al., 2011) demonstrated that BPC-157 accelerated the outgrowth of tendon explants and increased cell survival under oxidative stress conditions in rat Achilles tendon fibroblast cultures.
- A study in the Journal of Orthopaedic Research (Staresinic et al., 2003) examined transected rat Achilles tendons and observed improved biomechanical outcomes, functional indices, and collagen formation in BPC-157 treated groups.
- Research in Molecules (Chang et al., 2014) found that BPC-157 dose- and time-dependently increased growth hormone receptor expression in tendon fibroblasts at both mRNA and protein levels.
These findings reflect outcomes observed in controlled research settings and published study protocols. Individual experimental conditions, model organisms, and methodologies varied across studies. Results observed in preclinical and clinical research settings may not be generalizable.
Mechanism of Action
Research indicates BPC-157 may influence nitric oxide pathways, growth factor expression, and FAK-paxillin signaling involved in cell migration and tissue remodeling processes.
The mechanisms described above have been characterized through published research methodologies including receptor binding assays, gene expression analyses, cell culture experiments, and in vivo preclinical models. Mechanistic understanding continues to evolve as additional research is published.
Research Context
Tissue repair and regeneration represent one of the most actively investigated areas in peptide research. The study of bioactive peptides capable of influencing tissue remodeling pathways has expanded significantly over the past two decades, with researchers examining how short-chain peptides may interact with growth factor signaling, extracellular matrix formation, and cellular migration processes. Preclinical models have been used extensively to document peptide interactions with connective tissue, tendon, ligament, and mucosal structures. The field continues to attract attention from orthopedic and sports medicine researchers seeking to understand the molecular mechanisms underlying tissue homeostasis and repair. Published studies have employed a range of methodologies including in vitro cell culture, animal wound models, and biomechanical testing to characterize the effects of tissue-targeting peptides on collagen deposition, angiogenesis, and inflammatory pathway modulation.
BPC-157 has been studied within this broader research context. The compound is classified under the Tissue Research category and is part of the Recovery Series in the Hot Peps research catalog. Researchers investigating tissue research may find the published findings summarized above relevant to their experimental design and literature review processes.
Key Citations
The following references represent a selection of published studies relevant to BPC-157 research. Full-text articles may be accessed through their respective journal publishers or indexed databases such as PubMed.
- Vasireddi N, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. Orthop J Sports Med. 2025.PMID: 40756949
- Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing. J Appl Physiol. 2011;110(3):774-780.PMID: 21030672
- Staresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon. J Orthop Res. 2003;21(6):976-983.PMID: 14554208
This compound is part of the Recovery Stack — tissue & regeneration pathway focus.
View Kit →Important Notice
BPC-157 is sold exclusively for in vitro research, laboratory use, and scientific investigation purposes. This compound is not intended for human consumption, veterinary use, or any therapeutic application. It is not intended to diagnose, treat, cure, or prevent any disease or medical condition.
All research findings, statistics, and outcomes referenced on this page have been sourced from published peer-reviewed studies and scientific literature. These summaries are provided for informational purposes to support qualified researchers in their laboratory investigations. Results documented in published research were obtained under specific experimental conditions and may not be reproducible in all settings.
Researchers are responsible for ensuring that their use of research compounds complies with all applicable local, state, and federal regulations governing laboratory research materials.
Related Research Insights
BPC-157 Research Timeline
A chronological overview of BPC-157 research from initial isolation through current studies, covering key publications, expanding research areas, and the evolution of scientific understanding.
Mechanism ResearchAngiogenesis Signaling in Tissue Research
A comprehensive examination of blood vessel formation, VEGF signaling, nitric oxide pathways, and the documented research on BPC-157 and GHK-Cu in angiogenesis-related investigations.
Learn More About Peptide Research
All findings referenced on this page reflect outcomes reported in published research studies. This product is sold strictly for in vitro research, laboratory use, and scientific investigation only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease.